Transforming growth factor β is a growth-inhibitory cytokine of B cell lymphoma in SIV-infected macaques

AIDS Research and Human Retroviruses

Volumn 15, Issue 16, 1999, Pages 1477-1485

  Buske, Christian ^a,c   Hannig, Horst ^a   Schneider, Eva Maria ^a   Blaschke, Sabine ^b   Hunsmann, Gerhard ^b   Bodemer, Walter ^b   Hiddemann, Wolfgang ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b GERMAN PRIMATE CENTER   (Germany)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLIN; GLYCAN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; CELL VIABILITY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; GENETIC TRANSCRIPTION; HERPES VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; MACACA; MALE; MONKEY DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

ANIMALS; BASE SEQUENCE; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GROWTH INHIBITORS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, AIDS-RELATED; MACACA MULATTA; MOLECULAR SEQUENCE DATA; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0033230446     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299309991     Document Type: Article

References (43)

1. Gaidano G and Carbone A: AIDS-related lymphomas: From pathogenesis to pathology. Br J Hematol 1995;90:235-243.
2. Strauss DJ: HIV-associated lymphomas. Curr Opin Oncol 1997;9: 450-454.
3. Carpenter CCJ, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JSG, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, and Volberding PA: Antiretroviral therapy for HIV infection in 1997. JAMA 1997; 277:1962-1969.
4. Neri A, Barriga F, Inghirami G, Knowles DM, Neequaye J, Magrath IT, and Dalla-Favera R: Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphoma. Blood 1991;77:1092-1095.
5. Carbone A, Tirelli U, Gloghini A, Volpe R, and Boiocchi M: Human immunodeficiency-virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression. J Clin Oncol 1993;11:1674-1681.
6. Monroe JG and Silberstein LE: HIV-mediated B-lymphocyte activation and lymphomagenesis. J Clin Immunol 1995;15:61-68.
7. Ballerini P, Gaidano G, Gong JZ, Tassi V, Saglio G, Knowles DM, and Dalla-Favera R: Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Blood 1993;81:166-176.
8. Roithman S, Tourani JM, and Andrieu JM: AIDS-associated non-Hodgkin lymphoma. Lancet 1991;338:884-885.
9. Emilie D, Coumbaras J, Raphael M, Devergne O, Delecluse HJ, Gisselbrecht C, Michiels JF, Van Damme J, Taga T, Kishimoto T, Crevon MC, and Galanaud P: Interleukin-6 production in high-grade B lymphomas: Correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-seronegative patients. Blood 1992;80:498-504.
10. Benjamin D, Knobloch TJ, and Dayton MA; Human interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10. Blood 1992;80:1289-1298.
11. Emilie D, Touitou R, Raphael M, Peuchmaur M, Devergnee O, Rea D, Coumbaras J, Crevon M-C, Edelman L, Joab I, and Galanaud P: In vivo production of interleukin-10 by malignant cells in AIDS lymphomas. Eur J Immunol 1992;22:2937-2942.
12. Hannig H, Metz-Rensing K, Kuhn E-M, Stahl-Hennig C, Kaup F-J, Hunsmann G, and Bodemer W: Cytokine gene transcription in SIV and in HIV associated non-Hodgkin's lymhoma. AIDS Res Hum Retroviruses 1997;13:1589-1596.
13. Heinrich MC, Dooley DC, and Keeble WW: Transforming growth factor beta 1 inhibits expression of the gene products for steel factor and its receptor (c-Kit). Blood 1995;85:1769-1780.
14. Sott C, Dorner B, Karawajew L, Herrmann F, and Brach MA: Transforming growth factor-beta relieves stem cell factor-induced proliferation of myelogenous leukemia cells through inhibition of binding of the transcription factor NF-Jun. Blood 1992;84: 1950-1959.
15. Kehrl JH, Roberts AB, Wakefield LM, Jakowlew S, Sporn MB, and Fauci AS: Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes. J Immunol 1986;137:3855-3860.
16. Lee G, Namen AE, Gillis S, Ellingsworth LR, and Kincade PW: Normal B cell precursors responsive to recombinant murine IL-7 and inhibition of IL-7 activity by transforming growth factor-β. J Immunol 1989;142:3875-3883.
17. Buske C, Becker D, Feuring-Buske M, Hannig H, Wulf GG, Schäfer C, Hiddemann W, and Wörmann B: TGF-beta is a growth-inhibitory cytokine of normal and leukemic B-cell precursors. Leukemia 1997;11:386-392.
18. Rezikyan S, Kaaya EE, Ekman M, Voevodin AF, Feichtinger H, Putkonen P, Castanos-Velvez E, Biberfeld G, and Biberfeld P: B-cell lymphomagenesis in SIV-immunosuppressed cynomolgus monkeys. Int J Cancer 1995;61:574-579.
19. Pingel S, Hannig H, Mätz-Rennig K, Kaup F-J, Hunsmann G, and Bodemer W: Detection of Epstein-Barr virus small RNAs EBER1 and EBER2 in lymphomas of SIV-infected rhesus monkeys by in situ hybridization. Int J Cancer 1997;72:160-165.
20. Li SL, Feichtinger H, Kaaya E, Migliorini P, Putkonen P, Biberfeld G, Middeldorp JM, Biberfeld P, and Ernberg I: Expression of Epstein-Barr-virus-related nuclear antigens and B-cell markers in lymphomas of SIV-immunosuppressed monkeys. Int J Cancer 1993;55:609-615.
21. Mosman T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
22. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, and Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991;139:271-279.
23. Chomzynski P and Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
24. Zhang H, Shaw ARE, Mak A, and Letarte M: Endoglin is a component of the transforming growth factor (TGF)-β receptor complex of human pre-B leukemic cells. J Immunol 1996;156:565-573.
25. Franzen P, ten Dijke P, Ichijo H, Yamashita H, Schulz P, Heldin C-H, and Miyazono K: Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell 1993;75:681-692.
26. Lin HY, Wang XF, Ng-Eaton E, Weinberg RA, and Lodish HF: Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell 1992;68:775-785.
27. Li SL, Biberfeld P, and Ernberg I: DNA of lymphoma-associated herpesvirus (HVMF1) in SIV-infected monkeys (Macaca fascicularis) shows homologies to EBNA-1, -2, and -5 genes. Int J Cancer 1994;59:287-295.
28. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zboroeska E, Kinzler KW, Vogelstein B, Brattain M, and Willson KKV: Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 1995;268:1336-1338.
29. Knaus PI, Lindemann D, DeCoteau JF, Perlman R, Yankelev H, Hille M, Kadin ME, and Lodish HF: A dominant inhibitory mutant of the type II transforming growth factor β receptor in the malignant progression of a cutaneous T-cell lymphoma. Mol Cell Biol 1996;16:3480-3489.
30. Koli KM and Arteaga CL: Predominant cytosolic localization of type II transforming growth factor β receptors in human breast carcinoma cells. Cancer Res 1997;57:970-977.
31. Wrana JL, Attisano L, Wieser R, Ventura F, and Massague J: Mechanisms of activation of TGF-beta receptor. Nature (London) 1994;370:341-347.
32. Ohta M, Greenberger S, Anklesaria P, Bassols A, and Massague J: Two forms of transforming growth factor-β distinguished by multipotential hematopoietic progenitor cells. Nature (London) 1987;329:539-541.
33. Rokhlin OW, Cohen MB, Kubagawa H, Letarte M, and Cooper MD: Differential expression of endoglin on fetal and adult hematopoietic cells in human bone marrow. J Immunol 1995;154:4456-4465.
34. Lopez-Casillas F, Wrana JL, and Massaque J: Betaglycan presents ligand to the TGF-beta signaling receptor. Cell 1993;73:1435-1444.
35. Cheifetz ST, Bellon T, Cales C, Vera S, Bernebeau C, Massague J, and Letarte M: Endoglin is a component of the TGF-β receptor system in human endothelial cells. J Biol Chem 1992;267:19027-19030.
36. Roberts AB and Sporn MB: The transforming growth factors-betas. Peptide Growth Factors and Their Receptors (Sporn M and Roberts AB, eds.). Springer-Verlag, Heidelberg, Germany, 1990, p. 421.
37. Massague J, Cheifetz S, Laiho M, Ralph DA, Weis FM, and Zentella A: Transforming growth factor. Cancer Surv 1992;12:81-103.
38. Chaouchi N, Arvanitakis L, Auffredou MT, Blanchard DA, Vazquez A, and Sharma S: Characterization of transforming growth factor-beta 1 induced apoptosis in normal human B cells and lymphoma B cell lines. Oncogene 1995;11:1615-1622.
39. Beckwith M, Ruscetti FW, Sing GK, Urba WJ, and Longo DL: Anti-IgM induces transforming growth factor-beta sensitivity in a human B-lymphoma cell line: Inhibition of growth is associated with a downregulation of mutant p53. Blood 1995;85:2461-2470.
40. Kim IY, Ahn H-J, Zetner DJ, Shaw JW, Sensibar JA, Kim J-H, Kato M, and Lee C: Genetic change in transforming growth factor β (TGF-β) receptor type I gene correlates with insensitivity to TGF-β1 in human prostate cancer cells. Cancer Res 1996;56: 44-48.
41. Kadin ME, Cavaille-Coll MW, Gertz R, Massague J, Cheifetz S, and George D: Loss of receptors for transforming growth factor β in human T-cell malignancies. Proc Natl Acad Sci USA 1994;91: 6002-6006.
42. DeCoteau JF, Knaus PI, Yankelev H, Reis MD, Lowsky R, Lodish HF, and Kadin ME: Loss of functional cell surface transforming growth factor beta (TGF-beta) type I receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1997;94:5877-5881.
43. Amoroso SR, Huang N, Roberts AB, Potter M, and Letterio JJ: Consistent loss of functional transforming growth factor β receptor expression in murine plasmocytomas. Proc Natl Acad Sci USA 1998;95:189-194.